Paclitaxel is a chemotherapeutic agent marketed under the brand name Taxol among others. Used as a treatment for various cancers, paclitaxel is a mitotic inhibitor that was first isolated in 1971 from the bark of the Pacific yew tree which contains endophytic fungi that synthesize paclitaxel. It is available as an intravenous solution for injection and the n...
Used in the treatment of Kaposi's sarcoma and cancer of the lung, ovarian, and breast. Abraxane® is specfically indicated for the treatment of metastatic breast cancer and locally advanced or metastatic non-small cell lung cancer.
Division of Oncology, Department of Internal Medicine and Oncology, Semmelweis University, Budapest, Hungary
Peking University Cancer Hospital, Beijing, China
Hunan Cancer Hospital, Changsha, China
Sichuan Provincial People's Hospital, Chengdu, China
Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh
Texas Oncology, Dallas, Texas, United States
Ohio State University Center, Columbus, Ohio, United States
Baptist Health South Florida (BHSF) - Miami Cancer Institute, Miami, Florida, United States
Tianjin Medical University Cancer Institute and Hospital, Tianjin, China
Samsung Medical Center, Gangnam-Gu, Korea, Republic of
Centro de Atención e Investigación Clínica en Oncología, Yucatán, Mexico
Wojewodzki Szpital Specjalistyczny lm. Stefana Kardynala Wyszynsklego SPZOZ w Lublinie, Lublin, Poland
Pfizer Norway, Oslo, Norway
National Cancer Center Hospital, Chuo, Tokyo, Japan
Saint-Eloi Hospital - Montpellier (CHU), Montpellier, France
Saint-Joseph Hospital - Paris, Paris, France
ICM - Montpellier, Montpellier, France
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.